Longitudinal assessment of measured and estimated glomerular filtration-rate in autosomal dominant polycystic kidney disease: Real practice experience
Juan M Fernandez, José C Rodriguez-Pérez, M Mercedes Lorenzo-Medina, Fancisco Rodriguez-Esparragon, Juan C Quevedo-Reina, Carmen R Hernandez-Socorro
Juan M Fernandez, Medical Manager Southern Europe, Baxter Healthcare Ltd., Madrid 28830, Spain
Juan M Fernandez, Escuela de Doctorado, Universidad De Las Palmas De Gran Canaria, Las Palmas 35001, Canary Islands, Spain
José C Rodriguez-Pérez, Department of Research, Universidad Fernando Pessoa Canarias, Las Palmas 35450, Canary Islands, Spain
M Mercedes Lorenzo-Medina, Department of Clinical Chemistry, Hospital Universitario De Gran Canaria Doctor Negrín, Las Palmas 35010, Canary Islands, Spain
Fancisco Rodriguez-Esparragon, Department of Research, Hospital Universitario De Gran Canaria Doctor Negrín, Las Palmas 35010, Canary Islands, Spain
Juan C Quevedo-Reina, Department of Nephrology, Hospital Universitario De Gran Canaria Doctor Negrín, Las Palmas 35010, Canary Islands, Spain
Carmen R Hernandez-Socorro, Department of Radiology, Hospital Universitario De Gran Canaria Doctor Negrín, Las Palmas 35010, Canary Islands, Spain
Author contributions: Fernandez JM and Rodriguez-Pérez JC participated in the conception and design of the study and were involved in the acquisition, analysis and interpretation of data and process of writing; Lorenzo-Medina MM, Quevedo-Reina JC, and Hernandez-Socorro CR accessed and verified the study data; Rodriguez-Esparragon F analysis and writing; all authors contributed to the preparation and critical review of the manuscript, and approved the final manuscript.
Institutional review board statement: The study protocol received approval from the Ethics Committee of the HUGCDN (Protocol VO 05-2017; Review Board approval, No. 170071; May 2017).
Informed consent statement: The need for patient consent was waived due to the retrospective nature of the study. Nevertheless, prior to participation and inclusion in the prospective database, written informed consent was obtained from all patients.
Conflict-of-interest statement: None of the authors have any conflict of interest to declare. Neither honoraria nor payments were made for authorship of this article. All authors declare no proprietary interest.
Data sharing statement: The data underlying this article will be shared on reasonable request to the corresponding author.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
https://creativecommons.org/Licenses/by-nc/4.0/ Corresponding author: Juan M Fernandez, MD, Medical Manager Southern Europe, Baxter Healthcare Ltd., Parque Empresarial San Fernando-Edificio Londres, Madrid 28830, Spain.
docjuanfernandez@gmail.com
Received: July 11, 2024
Revised: December 7, 2024
Accepted: December 27, 2024
Published online: March 25, 2025
Processing time: 192 Days and 10 Hours
